Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 22 studies | 81% ± 25% | |
peripheral blood | 22 studies | 96% ± 13% | |
intestine | 14 studies | 84% ± 25% | |
brain | 12 studies | 45% ± 32% | |
kidney | 9 studies | 80% ± 20% | |
liver | 8 studies | 69% ± 22% | |
eye | 8 studies | 41% ± 23% | |
heart | 7 studies | 39% ± 14% | |
lymph node | 6 studies | 97% ± 4% | |
pancreas | 5 studies | 79% ± 26% | |
bone marrow | 5 studies | 84% ± 26% | |
placenta | 5 studies | 69% ± 36% | |
uterus | 5 studies | 95% ± 8% | |
esophagus | 5 studies | 47% ± 25% | |
prostate | 5 studies | 78% ± 27% | |
skin | 5 studies | 72% ± 34% | |
adipose | 4 studies | 67% ± 26% | |
stomach | 4 studies | 43% ± 26% | |
breast | 4 studies | 97% ± 4% | |
adrenal gland | 3 studies | 75% ± 26% | |
thymus | 3 studies | 73% ± 38% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
thymus | 100% | 101679.59 | 653 / 653 | 99% | 2111.20 | 599 / 605 |
lung | 100% | 206810.40 | 578 / 578 | 99% | 1667.37 | 1143 / 1155 |
intestine | 100% | 111262.06 | 966 / 966 | 99% | 1482.65 | 520 / 527 |
breast | 100% | 121136.68 | 459 / 459 | 98% | 1513.59 | 1099 / 1118 |
kidney | 100% | 89118.28 | 89 / 89 | 98% | 1946.27 | 883 / 901 |
esophagus | 99% | 56384.49 | 1429 / 1445 | 98% | 1306.46 | 180 / 183 |
prostate | 100% | 82102.77 | 244 / 245 | 98% | 1205.28 | 490 / 502 |
stomach | 99% | 63567.67 | 354 / 359 | 98% | 1418.97 | 281 / 286 |
liver | 100% | 64398.99 | 226 / 226 | 96% | 1142.32 | 388 / 406 |
bladder | 100% | 71746.33 | 21 / 21 | 95% | 1447.72 | 480 / 504 |
uterus | 100% | 81414.31 | 170 / 170 | 95% | 1813.36 | 434 / 459 |
adrenal gland | 100% | 99425.22 | 258 / 258 | 93% | 1272.62 | 215 / 230 |
skin | 100% | 81729.58 | 1805 / 1809 | 94% | 1760.16 | 442 / 472 |
ovary | 100% | 53601.56 | 180 / 180 | 91% | 953.47 | 393 / 430 |
pancreas | 57% | 19569.66 | 187 / 328 | 98% | 1854.51 | 175 / 178 |
brain | 56% | 20343.69 | 1471 / 2642 | 94% | 976.52 | 660 / 705 |
adipose | 100% | 142156.21 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 2909.71 | 29 / 29 |
spleen | 100% | 240978.61 | 241 / 241 | 0% | 0 | 0 / 0 |
peripheral blood | 100% | 274626.00 | 926 / 929 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 96058.34 | 1330 / 1335 | 0% | 0 | 0 / 0 |
heart | 98% | 49743.24 | 844 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 98% | 1686.19 | 44 / 45 |
muscle | 64% | 18386.35 | 510 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 53% | 651.14 | 42 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0050870 | Biological process | positive regulation of T cell activation |
GO_0002726 | Biological process | positive regulation of T cell cytokine production |
GO_2000774 | Biological process | positive regulation of cellular senescence |
GO_1900122 | Biological process | positive regulation of receptor binding |
GO_0019885 | Biological process | antigen processing and presentation of endogenous peptide antigen via MHC class I |
GO_0034756 | Biological process | regulation of iron ion transport |
GO_0007611 | Biological process | learning or memory |
GO_0071283 | Biological process | cellular response to iron(III) ion |
GO_0032092 | Biological process | positive regulation of protein binding |
GO_0002237 | Biological process | response to molecule of bacterial origin |
GO_0001913 | Biological process | T cell mediated cytotoxicity |
GO_0002481 | Biological process | antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-dependent |
GO_0007608 | Biological process | sensory perception of smell |
GO_0060586 | Biological process | multicellular organismal-level iron ion homeostasis |
GO_0006826 | Biological process | iron ion transport |
GO_0002503 | Biological process | peptide antigen assembly with MHC class II protein complex |
GO_0050680 | Biological process | negative regulation of epithelial cell proliferation |
GO_0001916 | Biological process | positive regulation of T cell mediated cytotoxicity |
GO_0048260 | Biological process | positive regulation of receptor-mediated endocytosis |
GO_0033077 | Biological process | T cell differentiation in thymus |
GO_1990000 | Biological process | amyloid fibril formation |
GO_0010977 | Biological process | negative regulation of neuron projection development |
GO_0006879 | Biological process | intracellular iron ion homeostasis |
GO_0002502 | Biological process | peptide antigen assembly with MHC class I protein complex |
GO_0045646 | Biological process | regulation of erythrocyte differentiation |
GO_1904434 | Biological process | positive regulation of ferrous iron binding |
GO_0042026 | Biological process | protein refolding |
GO_0071281 | Biological process | cellular response to iron ion |
GO_1904437 | Biological process | positive regulation of transferrin receptor binding |
GO_0019886 | Biological process | antigen processing and presentation of exogenous peptide antigen via MHC class II |
GO_0071316 | Biological process | cellular response to nicotine |
GO_0050778 | Biological process | positive regulation of immune response |
GO_1900121 | Biological process | negative regulation of receptor binding |
GO_2000978 | Biological process | negative regulation of forebrain neuron differentiation |
GO_0050768 | Biological process | negative regulation of neurogenesis |
GO_0051289 | Biological process | protein homotetramerization |
GO_0005615 | Cellular component | extracellular space |
GO_0009897 | Cellular component | external side of plasma membrane |
GO_0031902 | Cellular component | late endosome membrane |
GO_0005576 | Cellular component | extracellular region |
GO_0005886 | Cellular component | plasma membrane |
GO_0035580 | Cellular component | specific granule lumen |
GO_0016020 | Cellular component | membrane |
GO_0031901 | Cellular component | early endosome membrane |
GO_0055038 | Cellular component | recycling endosome membrane |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0005925 | Cellular component | focal adhesion |
GO_0000139 | Cellular component | Golgi membrane |
GO_0005788 | Cellular component | endoplasmic reticulum lumen |
GO_0042824 | Cellular component | MHC class I peptide loading complex |
GO_1904724 | Cellular component | tertiary granule lumen |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0005829 | Cellular component | cytosol |
GO_0042613 | Cellular component | MHC class II protein complex |
GO_0031905 | Cellular component | early endosome lumen |
GO_0030670 | Cellular component | phagocytic vesicle membrane |
GO_0042612 | Cellular component | MHC class I protein complex |
GO_0012507 | Cellular component | ER to Golgi transport vesicle membrane |
GO_1990712 | Cellular component | HFE-transferrin receptor complex |
GO_0005765 | Cellular component | lysosomal membrane |
GO_0042803 | Molecular function | protein homodimerization activity |
GO_0042802 | Molecular function | identical protein binding |
GO_0005198 | Molecular function | structural molecule activity |
GO_0023026 | Molecular function | MHC class II protein complex binding |
GO_0005515 | Molecular function | protein binding |
GO_0042605 | Molecular function | peptide antigen binding |
Gene name | B2M |
Protein name | Beta-2-microglobulin [Cleaved into: Beta-2-microglobulin form pI 5.3] Human nkt tcr alpha chain (Human nkt tcr beta chain) Beta 2-microglobulin protein (Beta-2-microglobulin) Human nkt tcr beta chain Beta-2-microglobulin |
Synonyms | beta hCG_1786707 CDABP0092 2-microglobulin HDCMA22P |
Description | FUNCTION: Component of the class I major histocompatibility complex (MHC). Involved in the presentation of peptide antigens to the immune system. Exogenously applied M.tuberculosis EsxA or EsxA-EsxB (or EsxA expressed in host) binds B2M and decreases its export to the cell surface (total protein levels do not change), probably leading to defects in class I antigen presentation . . |
Accessions | ENST00000559916.1 ENST00000631575.1 ENST00000557901.5 Q16446 F5H6I0 P61769 H0YLF3 ENST00000631573.1 ENST00000632867.1 ENST00000561139.2 ENST00000631728.1 ENST00000648006.3 ENST00000561424.5 ENST00000349264.10 K7N5M4 J3KNU0 ENST00000633158.1 K7N5M3 ENST00000617605.4 ENST00000619603.1 |